Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Immunogenetics ; 76(1): 69-74, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38030802

ABSTRACT

The immune regulator gene AIRE plays an essential role in the establishment of immune tolerance and the prevention of autoimmunity. This transcription factor plays a critical role in promoting self-tolerance in the thymus by regulating the expression of a large number of self-antigens that share the common feature of being tissue-restricted in their expression pattern in the periphery. Dysfunction of AIRE in humans causes a rare disease, autoimmune polyglandular syndrome type 1 (APS1), characterized by an autoimmune response against peripheral tissues, particularly endocrine tissues. Although a few dominant mutations have been described, the inactivation of AIRE is usually caused by recessive mutations. Recent data suggests that alterations in AIRE function contribute not only to APS1 but also to more common forms of autoimmune disease. Here, we present a previously unreported missense mutation (NM_000383.2:c.260 T > C) in exon 2 of the AIRE gene, predicted to cause the substitution (p.(Leu87Pro)) in the CARD domain of the AIRE protein. When inherited in conjunction with another dysfunctional AIRE allele, this mutation was associated with immune dysregulation in a pediatric patient. The presence of hypergammaglobulinemia, malabsorption syndrome, ectodermal dysplasia, mucocutaneous candidiasis, vitiligo, and hypothyroidism as well as the presence of multiple autoantibodies allowed us to confirm an APS1 diagnosis.


Subject(s)
Mutation, Missense , Polyendocrinopathies, Autoimmune , Child , Humans , AIRE Protein , Mutation , Polyendocrinopathies, Autoimmune/genetics , Polyendocrinopathies, Autoimmune/diagnosis , Transcription Factors/genetics , Transcription Factors/metabolism
2.
Front Immunol ; 12: 689484, 2021.
Article in English | MEDLINE | ID: mdl-34557187

ABSTRACT

Mast cells (MCs) are main effector cells in allergic inflammation and after activation, they release stored (histamine, heparin, proteases) and newly synthesized (lipid mediators and cytokines) substances. In the gastrointestinal tract the largest MC population is located in the lamina propria and submucosa whereas several signals such as the cytokine IL-4, seem to increase the granule content and to stimulate a remarkable expansion of intestinal MCs. The broad range of MC-derived bioactive molecules may explain their involvement in many different allergic disorders of the gastrointestinal tract. Annexin A1 (AnxA1) is a 37 KDa glucocorticoid induced monomeric protein selectively distributed in certain tissues. Its activity can be reproduced by mimetic peptides of the N-terminal portion, such as Ac2-26, that share the same receptor FPR-L1. Although previous reports demonstrated that AnxA1 inhibits MC degranulation in murine models, the effects of exogenous peptide Ac2-26 on intestinal MCs or the biological functions of the Ac2-26/FPR2 system in human MCs have been poorly studied. To determine the effects of Ac2-26 on the function of MCs toward the possibility of AnxA1-based therapeutics, we treated WT and IL-4 knockout mice with peptide Ac2-26, and we examined the spontaneous and compound 48/80 stimulated colonic MC degranulation and cytokine production. Moreover, in vitro, using human mast cell line HMC-1 we demonstrated that exogenous AnxA1 peptide is capable of interfering with the HMC-1 degranulation in a direct pathway through formyl peptide receptors (FPRs). We envisage that our results can provide therapeutic strategies to reduce the release of MC mediators in inflammatory allergic processes.


Subject(s)
Annexin A1/pharmacology , Cell Degranulation/drug effects , Colon/drug effects , Cytokines/metabolism , Inflammation Mediators/metabolism , Mast Cells/drug effects , Peptides/pharmacology , Animals , Cell Line , Colon/immunology , Colon/metabolism , Humans , Interleukin-4/genetics , Interleukin-4/metabolism , Male , Mast Cells/immunology , Mast Cells/metabolism , Mice, Inbred C57BL , Mice, Knockout , Receptors, Formyl Peptide/metabolism , Tissue Culture Techniques
3.
Microb Pathog ; 152: 104604, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33186743

ABSTRACT

The main cause of mastitis, one of the most costly diseases in the dairy industry, is bacterial intramammary infection. Many of these bacteria are biofilm formers. Biofilms have been associated with resistance to antibiotics and to the host immune system. Here, we evaluated different experimental models representing bacterial biofilm lifestyle with the aim to study bacterial invasion into bovine mammary epithelial cells and the interaction of these cells with planktonic or biofilm Staphylococcus aureus. Staphylococcus aureus V329, its nonbiofilm-forming mutant and bovine mammary alveolar cells (MAC-T) were used. Bacterial invasion was studied using the gentamicin exclusion test, cell viability by trypan blue exclusion technique, TLR2 expression by flow cytometry, IL1ß/IL6 production by ELISA and IL8/TNFα gene expression by real-time polymerase chain reaction. Biofilm and planktonic S. aureus showed differences in their invasion ability, with the biofilm mode showing a lower ability. Planktonic S. aureus reduced MAC-T viability after 6 h of co-culture, while biofilms did so at 24 h. MAC-T infected with planktonic bacteria showed increased TLR2 expression. Both lifestyles increased IL8 expression and IL1ß/IL6 production but did not modify TNFα expression. Our results demonstrate that the bacterial lifestyle affects the invasion behavior, suggesting that biofilms reduce the bacteria-epithelial cell interaction. Planktonic cultures seem to induce higher cellular activation than biofilms. Further knowledge about the complex host-biofilm interaction is necessary to design more efficient therapies against bovine mastitis.


Subject(s)
Mastitis, Bovine , Staphylococcal Infections , Animals , Biofilms , Cattle , Epithelial Cells , Female , Life Style , Plankton , Staphylococcal Infections/veterinary , Staphylococcus aureus
4.
Int J Biol Macromol ; 126: 60-67, 2019 Apr 01.
Article in English | MEDLINE | ID: mdl-30586583

ABSTRACT

Staphylococci are the main pathogens associated with hard-to-control intramammary infections in dairy cattle, and bacterial biofilms are suspected to be responsible for the antimicrobial resistance and persistence of this disease. Biofilms have the ability to resist to higher levels of antibiotics and reduce their efficacy. It is thus necessary to develop strategies targeted to bacterial biofilm infections. Chitosan is a polysaccharide with a proven broad spectrum of antimicrobial activity against fungi and bacteria. The aim of this study was assess the effect of low molecular weight (LMW) chitosan against biofilm hyperproducer Staphylococcus spp. (S. aureus and S. xylosus) strains usually involved in chronic bovine mastitis, and to test their efficacy in biofilm formation and eradication. The results obtained showed that LMW chitosan is able to inhibit S. aureus and S. xylosus planktonic growth in a dose-dependent manner and reduce bacterial viability. LMW chitosan inhibits biofilm formation, reduces biofilm viability and disrupts established biofilm. These results indicate the inhibitory effects of chitosan on biofilm formation, and these effects are observed at lower concentrations for S. xylosus. Our studies show the potential of this biopolymer to be used as an effective antibiofilm agent able to act upon staphylococcal infections.


Subject(s)
Biofilms/growth & development , Chitosan/pharmacology , Mastitis, Bovine/microbiology , Staphylococcus/growth & development , Staphylococcus/isolation & purification , Animals , Bacterial Adhesion/drug effects , Biofilms/drug effects , Cattle , Female , Microbial Sensitivity Tests , Microbial Viability/drug effects , Molecular Weight , Staphylococcus/drug effects , Staphylococcus/ultrastructure
5.
Biochem Pharmacol ; 115: 104-13, 2016 09 01.
Article in English | MEDLINE | ID: mdl-27343762

ABSTRACT

TNF-α is involved in the mechanisms that initiate inflammatory bowel diseases (IBDs). Anti-TNF-α drugs, such as infliximab (IFX), cause non-responsiveness and side effects, indicating the need to investigate alternative therapies for these diseases. The anti-inflammatory protein, annexin A1 (AnxA1), has been associated with the protection of the gastrointestinal mucosa. To further address the role of endogenous AnxA1 on the TNF-α blockade efficacy in a murine model, we assessed colitis induced by Dextran Sulfate Sodium (DSS) in wild-type (WT) and AnxA1(-/-) Balb/c mice treated with IFX. We consistently observed endogenous AnxA1 prevented clinical and physiological manifestations of experimental colitis treated with IFX, additionally the manifestation of the disease was observed earlier in AnxA1(-)(/-) mice. Rectal bleeding, diarrhea, histological score, epithelial damages and collagen degradation caused by DSS were prevented following IFX treatment only in WT mice. IL-6 increased during colitis in WT and AnxA1(-)(/-) mice, decreasing under IFX treatment in WT. The influx of neutrophils and TNF-α secretion were largely elevated in AnxA1(-)(/-) mice when compared to WT mice. In the group WT/DSS+IFX, phagocytes were more susceptible to apoptosis following treatment with IFX. Endogenous expression of AnxA1 increased after DSS and decreased with IFX treatment, demonstrating an attenuated inflammatory response. The data indicate that AnxA1 contributes to the establishment of intestinal homeostasis after blocking of TNF-α was used as a treatment of IBD, constituting a key molecule in the mechanism of action and a potential biomarker of therapeutic efficacy.


Subject(s)
Annexin A1/physiology , Colitis/drug therapy , Gastrointestinal Agents/therapeutic use , Infliximab/therapeutic use , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Animals , Annexin A1/deficiency , Biomarkers/metabolism , Caspase 3/metabolism , Colitis/chemically induced , Colitis/metabolism , Colitis/pathology , Dextran Sulfate , Female , Intestinal Mucosa/metabolism , Mice , Mice, Inbred BALB C , Peroxidase/metabolism
6.
Tumour Biol ; 37(1): 541-52, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26232323

ABSTRACT

The study of cellular interactions in the tumor microenvironment has become one of the main areas of research in the fight against cancer. Tumor-associated macrophages (TAMs) influence tumor progression and therapy response due to its functional plasticity. Regarding cancer treatment, photodynamic therapy (PDT) is a minimally invasive and clinically approved procedure that involves the administration of a photosensitizer (PS), a nontoxic photosensitizing drug which is selectively retained in neoplastic tissue. Here, we investigated the role of resident and nonresident macrophages in the context of a PDT-treated colorectal tumor by developing a combination of 2-D and three-dimensional (3-D) experimental platform, recreating tumor-stroma interactions in vitro. Enhancement of cytotoxicity of PDT was achieved in the presence of nonresident macrophages which had a strong anti-tumor phenotype mediated by the production of nitric oxide, IL-6, and tumor necrosis factor alpha (TNF-α). On the contrary, tumor resident macrophages induced a pro-tumor phenotype promoting tumor cell migration and endothelial stimulation. Due to their plasticity, tumor-resident or tumor-recruited macrophages can differentially influence the response of tumors to PDT, so their multifactorial roles should be considered in the overall design of anti-tumor therapeutic.


Subject(s)
Colorectal Neoplasms/drug therapy , Macrophages/cytology , Photochemotherapy/methods , Tumor Microenvironment/drug effects , Animals , Annexin A5/chemistry , Antineoplastic Agents/chemistry , Apoptosis , Arginase/chemistry , Cell Line, Tumor , Cell Movement , Cell Proliferation , Cell Survival , Culture Media, Conditioned/chemistry , Endothelial Cells/cytology , Enzyme-Linked Immunosorbent Assay , Humans , Imaging, Three-Dimensional , Interleukin-6/metabolism , Macrophages/drug effects , Macrophages/metabolism , Mice , Nitric Oxide/chemistry , Photosensitizing Agents/chemistry , Spheroids, Cellular/chemistry , Tumor Necrosis Factor-alpha/metabolism
7.
Immunobiology ; 220(11): 1210-8, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26101139

ABSTRACT

After Candida albicans arrival to the liver, the local production of proinflammatory cytokines and the expanded intrahepatic lymphocytes (IHL) can be either beneficial or detrimental to the host. Herein we explored the balance between protective inflammatory reaction and liver damage, focusing our study on the contribution of TNF-α and Fas-Fas-L pathways in the hepatocellular apoptosis associated to C. albicans infection. A robust tissue reaction and a progressive increase of IL-1ß, IL-6 and TNF-α were observed in infected animals. Blocking the biological activity of TNF-α did not modify the number of apoptotic cells observed in C. albicans infected animals. Fas-L molecule was up regulated on purified hepatic mononuclear cells and its expression progressed with the infection. In the IHL compartment, the absolute number of Fas-L+ NK and NKT cells increased on days 1 and 3 of the infection. C. albicans was also able to up regulate Fas-L expression in normal liver NK and NKT cells after in vitro contact. The innate receptor TLR2 was involved in this phenomenon. In the interplay between host factors and evasion strategies exploited by pathogens, the mechanism supported here could represent an additional way that allows this fungus to circumvent protective immune responses in the liver.


Subject(s)
Candida albicans/immunology , Fas Ligand Protein/genetics , Gene Expression Regulation , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Natural Killer T-Cells/immunology , Natural Killer T-Cells/metabolism , Animals , Apoptosis , Chemokines/genetics , Chemokines/metabolism , Cytokines/genetics , Cytokines/metabolism , Female , Hepatocytes/immunology , Inflammation/immunology , Inflammation/metabolism , Inflammation/microbiology , Inflammation/pathology , Liver/immunology , Liver/metabolism , Liver/microbiology , Liver/pathology , Rats , Signal Transduction , Toll-Like Receptor 2/genetics , Toll-Like Receptor 2/metabolism , Tumor Necrosis Factor-alpha/metabolism
8.
PLoS One ; 7(7): e40356, 2012.
Article in English | MEDLINE | ID: mdl-22848374

ABSTRACT

Dendritic cells (DC) have the potential to control the outcome of autoimmunity by modulating the immune response. In this study, we tested the ability of Fasciola hepatica total extract (TE) to induce tolerogenic properties in CpG-ODN (CpG) maturated DC, to then evaluate the therapeutic potential of these cells to diminish the inflammatory response in collagen induced arthritis (CIA). DBA/1J mice were injected with TE plus CpG treated DC (T/C-DC) pulsed with bovine collagen II (CII) between two immunizations with CII and clinical scores CIA were determined. The levels of CII-specific IgG2 and IgG1 in sera, the histological analyses in the joints, the cytokine profile in the draining lymph node (DLN) cells and in the joints, and the number, and functionality of CD4+CD25+Foxp3+ T cells (Treg) were evaluated. Vaccination of mice with CII pulsed T/C-DC diminished the severity and incidence of CIA symptoms and the production of the inflammatory cytokine, while induced the production of anti-inflammatory cytokines. The therapeutic effect was mediated by Treg cells, since the adoptive transfer of CD4+CD25+ T cells, inhibited the inflammatory symptoms in CIA. The in vitro blockage of TGF-ß in cultures of DLN cells plus CII pulsed T/C-DC inhibited the expansion of Treg cells. Vaccination with CII pulsed T/C-DC seems to be a very efficient approach to diminish exacerbated immune response in CIA, by inducing the development of Treg cells, and it is therefore an interesting candidate for a cell-based therapy for rheumatoid arthritis (RA).


Subject(s)
Adjuvants, Immunologic/pharmacology , Antigens, Helminth/pharmacology , Arthritis, Experimental/immunology , Dendritic Cells/immunology , Fasciola hepatica/chemistry , Forkhead Transcription Factors , Immune Tolerance/drug effects , Oligodeoxyribonucleotides/pharmacology , T-Lymphocytes, Regulatory/immunology , Animals , Antigens, Helminth/chemistry , Arthritis, Experimental/therapy , Arthritis, Rheumatoid/immunology , Arthritis, Rheumatoid/therapy , Cattle , Cell- and Tissue-Based Therapy , Immunization , Male , Mice , Transforming Growth Factor beta/immunology
9.
Int Immunol ; 24(5): 315-25, 2012 May.
Article in English | MEDLINE | ID: mdl-22345275

ABSTRACT

Hepatic mononuclear cells (HMC) are a heterogeneous population with innate immune properties involved in the response to several pathogens. Herein, during the primary infection with Candida albicans, we observed dynamic changes in CD3+, NK+ and NKT+ intrahepatic lymphoid subsets and a significant increase in the absolute number of antigen-presenting cells (APC). The liver tolerogenic microenvironment sustained by higher levels of IL-10, transforming growth factor-ß and IL-4 was severely modified upon the robust IFN-γ production after the fungal colonization. NKT cells purified from infected animals released significant amounts of IFN-γ and the production of this cytokine was exacerbated after a second contact with the fungus. Interestingly, C. albicans per se was unable to activate tolerogenic NKT cells from naive animals. In vitro experiments performed with HMC cells depleted of the CD11b/c+ population revealed that in the absence of APC, NKT cells are unable to produce IFN-γ in response to C. albicans. Our findings constitute the first evidence that this innate lymphocyte population is involved in the pathogenesis of C. albicans infection.


Subject(s)
Candida albicans/immunology , Candidiasis/immunology , Candidiasis/microbiology , Hepatocytes/immunology , Liver/immunology , Natural Killer T-Cells/immunology , Animals , Candida albicans/pathogenicity , Female , Flow Cytometry , Immunity, Innate , Liver/cytology , Liver/microbiology , Rats , Rats, Wistar
10.
Can J Microbiol ; 54(8): 647-59, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18772927

ABSTRACT

Virulence depends on opposing reactions between host and pathogen and is intrinsically linked to the host immune status. Virulence factors rely upon microbial attributes that mediate cell damage. While the activity of several Candida albicans hydrolytic enzymes is well characterized, the biological role of lipases is uncertain. In this report, we identified, isolated, and characterized a C. albicans 70 kDa lipase that exhibited maximal activity at physiological pH and temperature. We evaluated the ability of C. albicans lipase to interact with two types of mammalian host cells: macrophages, as crucial immune effector cells involved in fungal control, and hepatocytes, as examples of parenchymal cells compromised during fungal dissemination. Herein, we demonstrate for the first time that an extracellular lipase released by C. albicans directly induced cytotoxicity and promoted the deposition of lipid droplets in the cytoplasm of macrophages and hepatocytes.


Subject(s)
Candida albicans/enzymology , Candidiasis/immunology , Fatty Liver/immunology , Fungal Proteins/immunology , Lipase/immunology , Animals , Candida albicans/immunology , Candidiasis/microbiology , Cells, Cultured , Cytotoxicity, Immunologic , Fatty Liver/microbiology , Female , Fungal Proteins/genetics , Hepatocytes/immunology , Hepatocytes/microbiology , Humans , Lipase/genetics , Macrophages/immunology , Macrophages/microbiology , Rats , Rats, Wistar
11.
Rev. peru. biol. (Impr.) ; 14(2): 247-251, dic. 2007. tab
Article in Spanish | LIPECS | ID: biblio-1111193

ABSTRACT

Los hongos pueden causar enfermedades en humanos, especialmente en pacientes inmunosuprimidos. En este estudio, extractos de 10 plantas utilizadas en medicina popular en Argentina fueron ensayadas para estudiar la actividad antifúngica in vitro contra 4 cepas de hongos. De todas las plantas testeadas, solo 4 mostraron actividad antifúngica: Larrea divaricata Cav, Gnaphalium gaudichaudianum D.C, Baccharis trimera Less y Schinus terebenthifolius.


Fungi may cause very serious diseases in humans specially in immunosuppressed patients. In this study, extracts of 10 plants used in popular medicine in Argentine were assayed for in vitro antifungal activity against 4 fungal strains. Out of all the plants tested, Larrea divaricata Cav, Gnaphalium gaudichaudianum D.C, Baccharis trimera Less and Schinus terebenthifolius proved to have antifungal activity.


Subject(s)
Antifungal Agents , Antifungal Agents/therapeutic use , Plant Extracts/therapeutic use , Herbal Medicine , Potentilla
12.
Acta bioquím. clín. latinoam ; 41(2): 193-202, abr.-jun. 2007. ilus
Article in Spanish | LILACS | ID: lil-633004

ABSTRACT

El sistema inmune de mucosas del intestino presenta propiedades únicas: está expuesto a una gran variedad y cantidad de antígenos, desarrolla una actividad inmunológica permanente y mantiene un microambiente fisiológicamente desviado hacia respuestas anti-inflamatorias. Es capaz de distinguir y neutralizar agentes nocivos y reconocer antígenos inocuos, generando entonces un estado de no respuesta llamado tolerancia oral. Este fenómeno natural representa una forma fisiológica, segura e inocua de manipular las respuestas inmunes, para el tratamiento de enfermedades autoinmunes, inflamatorias o alérgicas. Aquellos compuestos que presenten la habilidad de favorecer la tolerancia permitirían optimizar el desarrollo de nuevos protocolos de inmunointervención. Quitosano (Q) es un polisacárido que abunda en la naturaleza con características fisicoquímicas y biológicas particulares: carece de toxicidad y alergenicidad, es biocompatible y biodegradable, presenta propiedades mucoadhesivas que favorecen el transporte y la absorción de proteínas a través del epitelio. Tiene actividad adyuvante, aumentando los niveles de IgA en la mucosa. Estas características lo convierten en un candidato ideal para la inmunointervención a nivel de mucosas. En este trabajo se describe el mecanismo de acción del Q luego de la administración oral, demostrando por primera vez que Q contribuye a mantener la homeostasis intestinal y a modular a nivel local y sistémico las respuestas inmunes hacia un antígeno proteico. Esta caracterización ayuda a comprender cómo participa un polisacárido en la fina regulación de las respuestas de mucosa y sugiere alternativas de manipulación que permitirán el desarrollo de terapias que requieran de microambientes anti-inflamatorios.


The mucosal immune system exhibits distinctive traits: it is permanently exposed to an overwhelming amount and variety of antigens; it maintains a continuous immune activity and it sustains a physiological environment biased to anti-inflammatory responses. Although it mounts efficient responses against pathogens, it reacts to innocuous antigens developing the oral tolerance state. Oral tolerance is a natural process that can be safely applied for the treatment of autoimmune, inflammatory or allergic diseases. Compounds able to promote the tolerance phenomenon can be used to optimize the development of alternative therapies. Chitosan (Q) is a natural and abundant polysaccharide with singular biological and physico-chemical properties that make it a good candidate to modulate the mucosal immunity: non toxic, biocompatible and biodegradable, strongly mucoadhesive favoring the transepithelial absorption of proteins and adjuvant, enhancing the levels of IgA to co-administered antigens. This work describes the Q activity mechanism early after its oral administration, for the first time showing, Q´s contribution to the intestinal homeostasis and also its modulation of the immune response to a protein antigen at local and systemic level. These studies will help understand how the intestinal regulatory activity occurs, and develop new therapeutic approaches to stimulate anti-inflammatory environments at mucosal level.


Subject(s)
Immunity, Mucosal , Chitosan/administration & dosage , Chitosan/immunology , Homeostasis/immunology , Immune System , Antigens/administration & dosage
13.
Int Immunol ; 16(12): 1761-8, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15528222

ABSTRACT

The liver constitutes the first barrier in the control of hematogenous dissemination for Candida albicans of intestinal origin. The ability of this organ to limit the growth of the yeast and to mount an efficient inflammatory reaction is crucial in determining the outcome of the fungal infection. When rats infected with C. albicans are exposed to chronic varied stress, the cell recruitment is impaired at the site of the infection, the tissue reaction is highly disorganized in target organs and the infection evolution is more severe. At hepatic level, higher fungal burden is associated with hyphal form and the consistent presence of steatosis (fatty liver). Herein we aimed at characterizing the steatosis associated with C. albicans infection and to provide molecular evidence of the correlation among liver injury markers, stress products and the initiation of the inflammatory tissue reaction. After 3 days of stress and infection, we observed micro and macro steatosis in acinar zone 1 (specific lipid stain), higher lipid peroxidation and increased levels of serum alanine aminotransferase and gamma glutamil transferase. While infection triggered hepatic NO production and arginase activity, stress down-modulated both. Remarkably, defects in levels of TNF-alpha and NO were observed during the first step of the inflammatory response. Our results demonstrate that stress mediators down-regulate the acute inflammatory reaction in the hepatic scenario, promoting a major liver injury with particular immunopathological traits.


Subject(s)
Candida albicans , Candidiasis/microbiology , Candidiasis/pathology , Fatty Liver/microbiology , Fatty Liver/pathology , Liver/pathology , Stress, Physiological/complications , Animals , Arginase/metabolism , Arginine/metabolism , Biomarkers/metabolism , Candidiasis/immunology , Fatty Liver/immunology , Female , Lipid Peroxidation , Liver/metabolism , Liver/microbiology , Rats , Rats, Wistar , Stress, Physiological/enzymology , Stress, Physiological/metabolism , Tumor Necrosis Factor-alpha/biosynthesis , Tumor Necrosis Factor-alpha/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...